Abstract
Motivation Identifying pathological metabolic changes in complex disease such as Dementia with Lewy Bodies (DLB) requires a deep understanding of functional modifications in the context of metabolic networks. Network determination and analysis from metabolomics and lipidomics data remains a major challenge due to sparse experimental coverage, a variety of different functional relationships between metabolites and lipids, and only sporadically described reaction networks.
Results Distance correlation, measuring linear and non-linear dependences between variables as well as correlation between vectors of different lengths, e.g. different sample sizes, is presented as an approach for data-driven metabolic network development. Additionally, novel approaches for the analysis of changes in pair-wise correlation as well as overall correlations for metabolites in different conditions are introduced and demonstrated on DLB data. Distance correlation and signed distance correlation was utilized to determine metabolic network in brain in DLB patients and matching controls and results for the two groups are compared in order to identify metabolites with the largest functional change in their network in the disease state. Novel correlation network analysis showed alterations in the metabolic network in DLB brains relative to the controls, with the largest differences observed in O-phosphocholine, fructose, propylene-glycol, pantothenate, thereby providing novel insights into DLB pathology only made apparent through network investigation with presented methods.
Competing Interest Statement
S.F.G. is supported by grants from the National Institute of Neurological Disorders and Stroke (1R01NS110838- 01A1), the National Institutes on Aging (1R21AG067083-01) and the Michael J. Fox Foundation (MJFF16201). All other authors declare no perceived or true conflicts of interest.
Funding Statement
S.F.G. is supported by grants from the National Institute of Neurological Disorders and Stroke (1R01NS110838- 01A1), the National Institutes on Aging (1R21AG067083-01) and the Michael J. Fox Foundation (MJFF16201).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Beaumont Health Systems Human Investigation Committee (HIC No.: 2018-387).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Availability: The SiDCo analysis application is freely available at https://complimet.ca/sidco; Matlab routines are available at https://github.com/complimet/SiDCo
Supplementary information: Supplementary data is provided at Bioinformatics online. Data used in the paper is made available at: https://doi.org/10.4224/40002692
Additional analysis methodology has been added and the presentation format is further improved with detailed information about the algorithms and methods used and further discussion of the results.
